Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effectiveness and Safety of Pembrolizumab, Quavonlimab, and Lenvatinib for Patients with Advanced Small Cell Lung Cancer Needing Second-Line Treatment

    Not recruiting

    1 1 1
    Austria Hungary Italy Poland Spain
  • Study on the Effectiveness of Inebilizumab for Patients with IgG4-Related Disease

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Poland Spain
  • Study on the Safety and Effectiveness of Isocyclosporin A Eye Drops for Adults with Atopic Keratoconjunctivitis

    Not recruiting

    1 1
    Investigated diseases:
    Italy
  • Long-term Safety Study of Emraclidine for Adults with Schizophrenia

    Not recruiting

    1 1
    Investigated drugs:
    Bulgaria Hungary
  • Study on Oxygen and Nitrous Oxide for Treating Dystonic and Plegic Attacks in Children with Alternating Hemiplegia

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Imlunestrant, Fulvestrant, Exemestane, and Abemaciclib for Patients with Advanced Estrogen Receptor Positive, HER2 Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Greece Italy +2
  • Study on the Effectiveness and Safety of Cryotherapy and Tirbanibulin for Actinic Keratosis in Organ Transplant Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany
  • Study on Insulin Lispro and Insulin Human for Managing Blood Sugar After Meals in Type 1 Diabetes Patients with Different Gastric Emptying Rates

    Not recruiting

    1 1 1
    Germany
  • Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

    Not recruiting

    1 1 1
    Austria Belgium Denmark France Germany Greece +5